Guillain-Barré syndrome in a child with serologic evidence of Borrelia burgdorferi infection.
Shapiro
E E
EE
Yale University School of Medicine, New Haven, CT, USA.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000907:Antibodies, Bacterial / Q000097:blood*; D015748:Borrelia burgdorferi Group / Q000276:immunology*; D002443:Ceftriaxone / Q000627:therapeutic use; D002648:Child; D006801:Humans; D008193:Lyme Disease / Q000150:complications* / Q000188:drug therapy; D008297:Male; D011129:Polyradiculoneuropathy / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D000907:Antibodies, Bacterial; D002443:Ceftriaxone